首页> 外文期刊>Cancer Immunology, Immunotherapy >Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)2 fragment of anti-CD16 antibody
【24h】

Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)2 fragment of anti-CD16 antibody

机译:抗CD16抗体的F(ab')2 片段快速有效诱导细胞死亡并丧失NK细胞对口腔肿瘤的细胞毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Freshly isolated untreated NK cells undergo rapid apoptosis and lose their cytotoxic function upon the addition of F(ab′)2 fragment of anti-CD16 antibodies. Loss of NK cell cytotoxic function after treatment with F(ab′)2 fragment of anti-CD16 antibody can be seen against K562 and UCLA-2 oral tumor cells when either added immediately in the co-cultures of NK cells with the tumor cells or after pre-treatment of NK cells with the antibody before their addition to the tumor cells. Addition of Interleukin-2 (IL-2) in combination with anti-CD16 antibody to NK cells delayed the induction of DNA fragmentation in NK cells, and even though decreased cytotoxicity could still be observed against K562 and UCLA-2 oral tumors when compared to IL-2 alone treated NK cells, the cytotoxicity levels remained relatively higher and approached those obtained by untreated NK cells in the absence of antibody treatment. No increases in IFN-γ, Granzymes A and B, Perforin and TRAIL genes could be seen in NK cells treated with anti-CD16 antibody. Neither secretion of IFN-γ nor increased expression of CD69 activation antigen could be observed after the treatment of NK cells with anti-CD16 antibody. Furthermore, IL-2 mediated increase in CD69 surface antigens was down-modulated by anti-CD16 antibody. Finally, the addition of anti-CD16 antibody to co-cultures of NK cells with tumor target cells was not inhibitory for the secretion of VEGF by oral tumor cells, unlike those co-cultured with untreated or IL-2 treated NK cells. Thus, binding and triggering of CD16 receptor on NK cells may enhance oral tumor survival and growth by decreased ability of NK cells to suppress VEGF secretion or induce tumor cell death during the interaction of NK cells with oral tumor cells.
机译:新鲜分离的未经处理的NK细胞在加入抗CD16抗体的F(ab')2 片段后会迅速凋亡并失去细胞毒功能。将抗CD16抗体的F(ab')2 片段处理后,立即加入NK细胞与NKLA细胞共培养时,可观察到针对K562和UCLA-2口腔肿瘤细胞的NK细胞细胞毒性功能丧失。或在将抗体加入肿瘤细胞之前,先用抗体对NK细胞进行预处理。向NK细胞中添加白介素2(IL-2)和抗CD16抗体可延缓NK细胞中DNA片段的诱导,尽管与K562和UCLA-2口腔肿瘤相比仍可观察到细胞毒性降低单独用IL-2处理的NK细胞,其细胞毒性水平保持相对较高,并接近于在没有抗体处理的情况下未经处理的NK细胞获得的细胞毒性水平。在用抗CD16抗体处理的NK细胞中未观察到IFN-γ,颗粒酶A和B,穿孔素和TRAIL基因的增加。用抗CD16抗体处理NK细胞后,既未观察到IFN-γ的分泌,也未观察到CD69活化抗原的表达增加。此外,IL-2介导的CD69表面抗原的增加被抗CD16抗体下调。最终,向NK细胞与肿瘤靶细胞共培养物中添加抗CD16抗体不抑制口服肿瘤细胞分泌VEGF,这与未处理或经IL-2处理的NK细胞共培养的那些不同。因此,在NK细胞与口腔肿瘤细胞相互作用期间,NK细胞抑制VEGF分泌或诱导肿瘤细胞死亡的能力降低,从而NK细胞上CD16受体的结合和触发可增强口腔肿瘤的存活和生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号